Skip to main content

Table 2 Antibiotic resistance pattern of 21 Pseudomonas aeruginosa isolates

From: Extended-spectrum beta-lactamase-producing Pseudomonas aeruginosa in camel in Egypt: potential human hazard

Antibiotic

No (%) resistant

No (%) sensitive

Amikacin (30 μg)

4 (19.0)

17 (81.0)

Imipenem (10 μg)

5 (23.8)

16 (76.2)

Gentamicin (10 μg)

6 (28.5)

15 (71.4)

Ciprofloxacin (5 μg)

7 (33.3)

14 (66.7)

Sulphamethoxazole/trimethoprim (25 µg)

8 (38.0)

13 (61.9)

Rifampicin (30 μg)

21 (100)

Ceftriaxone (30 μg)

21 (100)

Cefepime (30 μg)

20 (95.2)

1 (4.7)

Aztreonam (30 μg)

15 (76.1)

6 (28.5)

Meropenem (1.0 μg)

3 (14.2)

18 (85.8)

Ceftazidime (30 μg)

21 (100)